Olot

Researchers are collecting detailed information about patients with venous thromboembolism (VTE), which includes blood clots in veins such as deep-vein thrombosis and pulmonary embolism. The project aims to improve doctors' understanding of VTE, especially in patients often excluded from clinical trials, like pregnant women, elderly individuals, cancer patients, and those with other complex health issues. The goal is to reduce deaths, clot recurrence, bleeding problems, and artery-related events by sharing this knowledge widely. The study involves gathering extensive data on each patient's health status, treatments, and outcomes during the first three months of therapy. This registry is available online to help doctors quickly find information on patients with similar medical profiles and make informed decisions about managing high-risk individuals. There are no specific interventions being tested; instead, the focus is on collecting real-world patient data. Participants provide informed consent and are followed for at least three years to monitor for new clot events and complications. Researchers track recurrences of VTE, bleeding episodes, and deaths, aiming to create tools that predict which patients are most at risk for problems. This ongoing data collection supports improving care and guiding treatment decisions for diverse patient groups over time.

The study focuses on older adults aged 70 or more who are living at home with complex health and social needs. It aims to evaluate the ADMIT program, a multi-component integrated home care approach supported by technology, to see if it can increase the percentage of days these frail elderly people spend at home compared to usual care. The research also examines whether the program can reduce health or social crises, improve quality of life for patients and caregivers, and enhance the experience of all involved in the care system. Participants will receive care through the ADMIT integrated care program, which is co-created by professionals, patients, and caregivers. The program includes proactive detection of candidates, assignment of reference professionals from health and social services, shared diagnosis and care planning, and joint follow-up. A technological platform supports information sharing and communication among all parties. Additionally, sensor and robotic devices may be used in some cases to monitor and assist home care. During the study, participants' time spent at home over a 6-month intervention period will be tracked as the primary outcome. Researchers will also assess the program's impact on emergency care or hospitalizations, cost-effectiveness, and participants' and caregivers' experiences. The evaluation uses a pragmatic randomized controlled trial design with mixed methods to measure effectiveness, safety, and implementation factors. The program's adoption potential in Catalonia's health system will also be explored.